Cancer: drivers and passengers.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

80 citing papers in PubMed.

1. Comprehensive pan-cancer analysis of TRAP1 and its experimental validation in hepatocellular carcinoma.Discover oncology · 2025
   Article
2. A forward genetic screen identifies potassium channel essentiality in SHH medulloblastoma maintenance.Developmental cell · 2025
   Article
3. Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms.Cancers · 2025
   Review
4. Identifying somatic driver mutations in cancer with a language model of the human genome.Computational and structural biotechnology journal · 2025
   Article
5. Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC.Journal of translational medicine · 2024
   Article
6. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.Breast cancer research : BCR · 2023
   Article
7. Building a large gene expression-cancer knowledge base with limited human annotations.Database : the journal of biological databases and curation · 2023
   Article
8. Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer.Pharmaceuticals (Basel, Switzerland) · 2023
   Review
9. DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations.Nucleic acids research · 2023
   Article
10. Construction and analysis of sample-specific driver modules for breast cancer.BMC genomics · 2022
    Article
11. Prospects and challenges of cancer systems medicine: from genes to disease networks.Briefings in bioinformatics · 2022
    Review
12. driveR: a novel method for prioritizing cancer driver genes using somatic genomics data.BMC bioinformatics · 2021
    Article
13. Computational studies of anaplastic lymphoma kinase mutations reveal common mechanisms of oncogenic activation.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
14. Patient-matched analysis identifies deregulated networks in prostate cancer to guide personalized therapeutic intervention.American journal of cancer research · 2021
    Article
15. Improvement of Neoantigen Identification Through Convolution Neural Network.Frontiers in immunology · 2021
    Article
16. Progress in Neoantigen Targeted Cancer Immunotherapies.Frontiers in cell and developmental biology · 2020
    Review
17. Prioritizing Cancer Genes Based on an Improved Random Walk Method.Frontiers in genetics · 2020
    Article
18. ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification.Bioinformatics (Oxford, England) · 2019
    Article
19. Overview of the genetic basis toward early detection of breast cancer.Breast cancer (Dove Medical Press) · 2019
    Review
20. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications.International journal of medical sciences · 2019
    Review

20 more citing papers are in PubMed but not listed here.

Corrections and comments

• Comment on
  Patterns of somatic mutation in human cancer genomes.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as